Literature DB >> 6854734

Pharmacokinetics of erythromycin in foals and in adult horses.

J F Prescott, D J Hoover, I R Dohoo.   

Abstract

The pharmacokinetic parameters of erythromycin in foals were determined following intravenous administration of 5.0 mg/kg to animals aged 1, 3, 5 and 7 weeks. The distribution of the drug was described by a two-compartment open model, and no significant differences were observed between coefficients on which the parameters were based. Pharmacokinetic values were also determined for four mares given 5.0 mg/kg intravenously and for six 10-12-week-old foals given 20.0 mg/kg intravenously. The half-life of erythromycin for all groups of animals (foals less than 7 weeks, mares, foals 10-12 weeks) was 1.0-1.1 h; the apparent volume of distribution was between 2.3 and 7.2 l/kg, and the clearance of the drug from the body was between 1.9 and 5.0 mg/kg/h. No drug could be detected in the serum following oral administration of 5.0 mg/kg erythromycin estolate; detectable levels were found for 5 h in mares given 12.5 mg/kg, and for 8 h in foals given 20.0 mg/kg orally. Peak levels in foals given the drug orally were 0.42 micrograms/ml at 120 min after administration. Foals given 10.0 mg/kg of erythromycin base intramuscularly had serum concentrations detectable 12 h later; the peak level achieved was 1.44 micrograms/ml serum 90 min after administration and concentrations exceeded 0.25 micrograms/ml for 6 h. In the mares the milk concentrations were approximately twice those in serum. Recommendations were made for drug dosage to be used in the treatment of Corynebacterium equi pneumonia of foals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6854734     DOI: 10.1111/j.1365-2885.1983.tb00456.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  3 in total

Review 1.  Equine gastrointestinal motility--ileus and pharmacological modification.

Authors:  Judith Koenig; Nathalie Cote
Journal:  Can Vet J       Date:  2006-06       Impact factor: 1.008

2.  Emergence of rifampin-resistant Rhodococcus equi in an infected foal.

Authors:  S Takai; K Takeda; Y Nakano; T Karasawa; J Furugoori; Y Sasaki; S Tsubaki; T Higuchi; T Anzai; R Wada; M Kamada
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

3.  The influence of age on the pharmacokinetics of aditoprim in pigs after intravenous and oral administration.

Authors:  J L Riond; P Müller; M Wanner
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.